Acute Myeloid Leukemia | Tumor

CURE’s acute myeloid leukemia page features the latest cancer news and updates on acute myeloid leukemia. Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in acute myeloid leukemia.

On Alcohol Addiction for the Patient With Cancer

March 10th 2025, 5:00pm

Article

As a cancer survivor, I overcame alcohol addiction and urge others to seek support, safe detox and sobriety to improve their treatment and recovery.

Tuspetinib Triplet Is Safe and Has Antileukemic Activity in Newly Diagnosed AML

February 21st 2025, 2:00pm

Article

Treatment with tuspetinib in combination with Venclexta and Vidaza in newly diagnosed acute myeloid leukemia showed safety and antileukemic activity.

Breaking Down Cancer Therapies Approved by the FDA in January 2025

February 3rd 2025, 4:00pm

Article

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations like AML, MDS and breast cancer.

Galinpepimut-S Immunotherapy Has Preliminary Efficacy in Acute Myeloid Leukemia

January 30th 2025, 10:00pm

Article

Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission following second-line salvage therapy.

FDA Approves GRAFAPEX/Fludarabine Before alloHSCT in AML and MDS

January 24th 2025, 4:15pm

Article

The FDA has approved GRAFAPEX™ and fludarabine as a preparative regimen in acute myeloid leukemia or myelodysplastic syndrome prior to alloHSCT.

To Those Facing End of Life From Cancer

December 27th 2024, 6:00pm

Article

We, survivors, often express our gratitude for life, love, support and research, but what about the patients who do not experience positive outcomes from treatment?

My Dog and Thoughts of Gratitude After Cancer

December 16th 2024, 6:00pm

Article

During this holiday season, I wanted to take a moment and reflect on how my dog Payton stayed by my side during acute myeloid leukemia.

Uproleselan Fails to Improve Survival in AML, Although Some Subgroups May Benefit

December 10th 2024, 4:00pm

Article

A Phase 3 trial of uproleselan failed to improve overall survival in relapsed/refractory AML, though it may benefit primary refractory patients.

It's OK Not to Have Full Holiday Spirit During Cancer

November 20th 2024, 6:00pm

Article

During the holiday season, overwhelming feelings are OK to have, whether you are a patient with cancer or a caregiver.

Venclexta Regimen Beneficial for Patients with AML and MDS

November 19th 2024, 8:00pm

Article

Researchers have found an overall survival benefit and manageable safety profile with Venclexta for patients with AML and MDS.